Cases & Investigations
Berger Montague was Co-Lead Class Counsel in a nationwide class action settlement in the United States District Court for the District of Oregon. The action alleged that Bank of America, N.A. schemed to require certain borrowers to (1) purchase flood insurance at inflated cost due to the bank’s conduct, and (2) purchase flood insurance coverage in excess of the amount required by their mortgage contract or federal law.
The firm, led by Harold Berger, served as co-lead counsel and obtained a $30 million settlement for damages resulting from a very large oil spill.
As co-lead counsel representing the New Hampshire Retirement System, Berger Montague also helped secure substantial corporate governance benefits.
Berger Montague, PC is Lead Counsel in this securities fraud class action involving Bally Total Fitness Holding Corporation (“Bally”).
Berger Montague represents a class of shareholders who alleged that the lab equipment maker, Beckman Coulter, Inc., did not disclose product quality and regulatory issues that hurt the company’s stock price in a timely fashion.
Berger Montague, together with co-counsel, prosecuted this national class action against Central States Health And Life Company of Omaha (CSO) concerning CSO Cancer Policies.
The firm served as co-lead counsel and obtained a settlement of $12.5 million with McDonald’s in 2002 stemming from its failure to disclose the use of beef fat in its french fries.
Berger Montague is investigating possible claims against Boeing on behalf of current and former Boeing employees who participated in the company’s Voluntary Investment Plan, investing at least some of their account assets in Boeing stock.
The firm served as co-lead counsel and obtained a settlement of $2 million on behalf of a class of African American employees of Rochester Gas & Electric Co. to resolve charges of racial discrimination in hiring, job assignments, compensation, promotions, discipline, terminations, retaliation, and a hostile work environment.
The firm served as co-lead counsel in this antitrust price-fixing class action on behalf of a class of purchasers of brand name prescription drugs.